Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02970045 · ClinicalTrials.gov registry record
Norris ORIEN Total Cancer Care
A clinical trial of Malignant Neoplasm and Cancer Risk, sponsored by University of Southern California.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT02970045 is a study of Malignant Neoplasm and Cancer Risk that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 10,000 participants, above the 344-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (2807% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02970045, a study of Malignant Neoplasm and Cancer Risk, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This research trial collects biological samples and clinical information to create a repository of data from patients with cancer or a predisposition for cancer. Combining genetic information from biological samples and clinical data may lead to more knowledge about why certain cancers respond to treatment and help create more personalized medicine.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Medical Chart Review
- PROCEDURE Evaluation of Cancer Risk Factors
Study Locations (1)
California
- USC / Norris Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2016-05-02 |
| Est. Completion | 2037-05-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02970045
The ClinicalTrials.gov registry entry for NCT02970045 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 344-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (2807% higher). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT02970045 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02970045 about?
NCT02970045 is a clinical study titled "Norris ORIEN Total Cancer Care". This research trial collects biological samples and clinical information to create a repository of data from patients with cancer or a predisposition for cancer. Combining genetic information from biological samples and clinical data may lead to more knowledge about why certain cancers respond to tr...
What is the current status of trial NCT02970045?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2016-05-02. Estimated completion is 2037-05-02.
What conditions does trial NCT02970045 study?
This clinical trial studies the following conditions: Malignant Neoplasm, Cancer Risk.
What interventions are being tested in trial NCT02970045?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Medical Chart Review (OTHER), Evaluation of Cancer Risk Factors (PROCEDURE).
Who is sponsoring clinical trial NCT02970045?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02970045 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
RECRUITING · Phase 1
-
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
RECRUITING · Phase 3
-
Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
RECRUITING
-
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RECRUITING · Phase 1
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.